Form4insider filings, from the source

SEC Form 4 · accession 0001632388-15-000002

Nexvet Biopharma plc · NVET

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Geraldine T Farrell
Officer — VP Operations & Genl Counsel
Period of report
Feb 10, 2015
Accepted (ET)
Feb 10, 2015 · 2:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2Feb 10, 2015C36—A76IBy Nexvet EBT Limited
Ordinary SharesF3,F2Feb 10, 2015C56—A132IBy Nexvet EBT Limited
Ordinary SharesF3,F4Feb 10, 2015C1,696—A7,891IBy Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Investment Preference SharesF1,F2—Feb 10, 2015C36D——Ordinary Shares360I
Series B Preference SharesF3,F2—Feb 10, 2015C56D——Ordinary Shares560I
Series B Preference SharesF3,F4—Feb 10, 2015C1,696D——Ordinary Shares1,6960I

Explanation of responses